Comparison on the Effect and Safety of Dapagliflozin or Gliclazide Sustained Release Tablets Combined with Insulin Glargine in the Patients with Type 2 Diabetes Mellitus

SUN Junwei; YU Haiyan; ZHANG Xiaolan

doi:10.14033/j.cnki.cfmr.2020.28.001

Home>Articles>Comparison on the Effect and Safety of Dapagliflozin or Gliclazide Sustained Release Tablets Combined with Insulin Glargine in the Patients with Type 2 Diabetes Mellitus

DOI: 10.14033/j.cnki.cfmr.2020.28.001

Comparison on the Effect and Safety of Dapagliflozin or Gliclazide Sustained Release Tablets Combined with Insulin Glargine in the Patients with Type 2 Diabetes Mellitus

SUN Junwei

YU Haiyan

ZHANG Xiaolan

Machine-generated Keywords：

Publication Date：2020-10-05

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 1-4 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2020,18(28)